Q-omics provides the consensus-scored MTND6P20 profile across patient tissues and cancer cell-line models. MTND6P20 expression is associated with patient survival in 6 of 34 cancer types, with the highest sampling consensus in SKCM. Additionally, MTND6P20 RNA expression shows 8,291 significant gene co-expression associations, with the highest sampling consensus in LUSC. Together, these results highlight SKCM, and LUSC as cancer lineages where MTND6P20 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for MTND6P20 — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Survival associations

This table summarizes MTND6P20 survival associations across molecular data types. MTND6P20 RNA expression shows survival associations in the most cancer types (6). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.

MTND6P20 data type	Survival analysis	Lineage consensus	Lineage of highest sampling consensus
RNA	Kaplan–Meier	6	KIRC (90)	view →

This table ranks reproducible MTND6P20 RNA expression–survival associations across cancer types. High MTND6P20 expression shows unfavorable associations in SKCM, KIRC, BLCA, STAD, LGG and READ. The SKCM Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify SKCM as the clearest survival context for MTND6P20 RNA expression.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
SKCM	OS	Tertile	All	0.153	0.781	<.001	90	view →
KIRC	OS	Tertile	II,III,IV	0.588	0.793	.006	90	view →
BLCA	OS	Tertile	III,IV	0.051	0.684	<.001	72	view →
STAD	DFS	Tertile	All	0.473	0.665	.027	27	view →
LGG	DFS	Tertile	All	0.393	0.744	<.001	27	view →
READ	DFS	Tertile	All	0.163	0.566	.016	27	view →

Pink = unfavorable, green = favorable. all 6 lineages →

MTND6P20-SKCM (OS)

Kaplan–Meier survival curve for MTND6P20 RNA expression in SKCM: high vs low expression groups.

Explore this curve interactively →

Cross-omics associations

This table shows molecular features associated with MTND6P20 in patient tissues and cancer cell lines. In patient samples, MTND6P20 shows the broadest associations at the RNA and protein expression levels, with LUSC recurring as the lineage with the largest associated feature set.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
RNA	8,291	LUSC (4677)	view →
Function (RNA)	1,183	HNSC (612)	view →